DK160429C - N-heterocyclisk glycosid med antitumorvirkning, fremstilling deraf samt farmaceutisk praeparat indeholdende glycosidet - Google Patents

N-heterocyclisk glycosid med antitumorvirkning, fremstilling deraf samt farmaceutisk praeparat indeholdende glycosidet

Info

Publication number
DK160429C
DK160429C DK035684A DK35684A DK160429C DK 160429 C DK160429 C DK 160429C DK 035684 A DK035684 A DK 035684A DK 35684 A DK35684 A DK 35684A DK 160429 C DK160429 C DK 160429C
Authority
DK
Denmark
Prior art keywords
glycoside
antitumum
heterocyclic
effects
preparation
Prior art date
Application number
DK035684A
Other languages
Danish (da)
English (en)
Other versions
DK160429B (da
DK35684A (da
DK35684D0 (da
Inventor
Jr Donald Edward Nettleton
James Allen Bush
William Turnbull Bradner
Terence William Doyle
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DK35684D0 publication Critical patent/DK35684D0/da
Publication of DK35684A publication Critical patent/DK35684A/da
Publication of DK160429B publication Critical patent/DK160429B/da
Application granted granted Critical
Publication of DK160429C publication Critical patent/DK160429C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365—Nocardia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK035684A 1983-01-28 1984-01-26 N-heterocyclisk glycosid med antitumorvirkning, fremstilling deraf samt farmaceutisk praeparat indeholdende glycosidet DK160429C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/461,817 US4487925A (en) 1983-01-28 1983-01-28 Rebeccamycin and process for its preparation
US46181783 1983-01-28

Publications (4)

Publication Number Publication Date
DK35684D0 DK35684D0 (da) 1984-01-26
DK35684A DK35684A (da) 1984-07-29
DK160429B DK160429B (da) 1991-03-11
DK160429C true DK160429C (da) 1991-08-19

Family

ID=23834041

Family Applications (1)

Application Number Title Priority Date Filing Date
DK035684A DK160429C (da) 1983-01-28 1984-01-26 N-heterocyclisk glycosid med antitumorvirkning, fremstilling deraf samt farmaceutisk praeparat indeholdende glycosidet

Country Status (15)

Country Link
US (1) US4487925A (fi)
EP (1) EP0115350B1 (fi)
JP (1) JPS59141597A (fi)
KR (1) KR910002856B1 (fi)
AT (1) ATE36540T1 (fi)
AU (1) AU564256B2 (fi)
CA (1) CA1220149A (fi)
DE (1) DE3473459D1 (fi)
DK (1) DK160429C (fi)
ES (1) ES8607396A1 (fi)
FI (1) FI77264C (fi)
GR (1) GR81748B (fi)
IE (1) IE56651B1 (fi)
PT (1) PT78019B (fi)
ZA (1) ZA84582B (fi)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9320040B2 (en) 2010-02-26 2016-04-19 E-Blink Method and device for sending/receiving electromagnetic signals received/sent on one or more first frequency bands

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524145A (en) * 1984-09-04 1985-06-18 Bristol-Myers Company 4'-Deschlororebeccamycin pharmaceutical composition and method of use
US4567143A (en) * 1984-09-04 1986-01-28 Bristol-Myers Company Process for preparing 4'-deschlororebeccamycin
US4743594A (en) * 1984-09-17 1988-05-10 Schering Corporation Antibiotic, antitumor compounds and their use
US4764510A (en) * 1986-04-11 1988-08-16 Eli Lilly And Company Antibiotic A42125 and process for its production
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
US4808613A (en) * 1986-11-21 1989-02-28 Bristol-Myers Company Rebeccamycin derivative containing pharmaceutical composition
US5158938A (en) * 1990-03-06 1992-10-27 Bristol-Myers Squibb Company Rebeccamycin
IL97233A (en) 1990-03-06 1995-03-30 Bristol Myers Squibb Co Analogs of rabamycin, their manufacture and pharmaceutical preparations containing them
US5344823A (en) * 1990-03-06 1994-09-06 Bristol-Myers Squibb Company Antitumor antibiotic BMY-41219
EP0445736A1 (en) * 1990-03-06 1991-09-11 Bristol-Myers Squibb Company Rebeccamycin analog and pharmaceutical composition containing it
US5478813A (en) * 1990-05-11 1995-12-26 Banyu Pharmaceutical Co., Ltd. Antitumor substance BE-13793C derivatives
EP0630242B1 (en) * 1992-03-20 1999-01-20 The Wellcome Foundation Limited Further indole derivatives with antiviral activity
US6653290B2 (en) 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
US6677450B2 (en) 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
SK12022003A3 (sk) 2001-03-22 2004-05-04 Bristol-Myers Squibb Company Na topoizomerázu I selektívne cytotoxické cukrové deriváty indolpyrolkarbazolov
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
FR2990315B1 (fr) 2012-05-04 2014-06-13 Blink E Procede de transmission d'informations entre une unite emettrice et une unite receptrice

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9320040B2 (en) 2010-02-26 2016-04-19 E-Blink Method and device for sending/receiving electromagnetic signals received/sent on one or more first frequency bands

Also Published As

Publication number Publication date
KR910002856B1 (ko) 1991-05-06
EP0115350B1 (en) 1988-08-17
FI77264C (fi) 1989-02-10
FI840301A (fi) 1984-07-29
AU2372084A (en) 1984-08-02
GR81748B (fi) 1984-12-12
DE3473459D1 (en) 1988-09-22
FI77264B (fi) 1988-10-31
ES529170A0 (es) 1986-05-16
DK160429B (da) 1991-03-11
JPH0452280B2 (fi) 1992-08-21
DK35684A (da) 1984-07-29
PT78019B (en) 1986-06-18
CA1220149A (en) 1987-04-07
ZA84582B (en) 1984-09-26
AU564256B2 (en) 1987-08-06
KR840007257A (ko) 1984-12-06
FI840301A0 (fi) 1984-01-25
JPS59141597A (ja) 1984-08-14
US4487925A (en) 1984-12-11
IE56651B1 (en) 1991-10-23
EP0115350A2 (en) 1984-08-08
EP0115350A3 (en) 1985-09-18
IE840201L (en) 1984-07-28
DK35684D0 (da) 1984-01-26
PT78019A (en) 1984-02-01
ES8607396A1 (es) 1986-05-16
ATE36540T1 (de) 1988-09-15

Similar Documents

Publication Publication Date Title
DK160429C (da) N-heterocyclisk glycosid med antitumorvirkning, fremstilling deraf samt farmaceutisk praeparat indeholdende glycosidet
ES8801925A1 (es) Procedimiento para la fabricacion de derivados gangliosidos
GR930300130T1 (en) Modified ribozymes
NL191308C (nl) Gelyofiliseerd, na oplossing injecteerbaar preparaat dat een antracycline-glycoside bevat, alsmede werkwijze voor de bereiding van een injecteerbare oplossing van een antracycline-glycoside.
EP0513067A4 (en) A pratical synthesis of 2'-deoxynucleosides and 2',3'-dideoxy-2',3'-didehydronucleosides
GB1469862A (en) Therapeutic compositions containing etherified monosaccharide derivatives and method of using the same
SE8202439L (sv) 4'-jodderivat av antracyklinglykosider
HK32492A (en) Drug preparations of reduced toxicity
GB1297398A (fi)
DK0804228T3 (da) Lægemiddel indeholdende aktiveringspeptidet for protein C
GB1187825A (en) Ribofuranosyl Derivatives
DE3064798D1 (en) Pentadecapeptide, process for the preparation thereof and immunopotentiating agent
IT8821570A0 (it) Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante.
AU8640091A (en) Human interferon-gamma4-134, functional equivalents thereof and methods of using and compositions employing these materials
KR870010080A (ko) 면역촉진 활성을 갖는 트리펩티드
IT8567410A1 (it) Sistema di apertura regolabile dei versoi posteriori e regolazione dell'inclinazione rispetto al piano di lavoro per rincalzatori.
GB1491358A (en) Pharmaceutical materials
JPS523079A (en) Prepartion of amionuclesides
CA837052A (en) Pharmaceutical preparations containing 5-methylamino-2'-deoxy uridine
IL86824A (en) Antitumor agent obtained by microbial stereoselective reduction of 4'-deoxy-4'-iododoxorubicin to 4'-deoxy-13(s)-dihydro-4'-iododoxorubicin

Legal Events

Date Code Title Description
PBP Patent lapsed